BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O, Ludolph AC, Dupuis L; GERP ALS Study Group. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain 2016;139:1106-22. [PMID: 26984187 DOI: 10.1093/brain/aww004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 González De Aguilar JL. Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Front Neurol 2019;10:284. [PMID: 31019485 DOI: 10.3389/fneur.2019.00284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
2 Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Meyer T, Petri S, Hermann A, Emmer A, Grosskreutz J, Grehl T, Zeller D, Boentert M, Schrank B, Prudlo J, Winkler AS, Gorbulev S, Roselli F, Schuster J, Dupuis L; LIPCAL-ALS Study Group. Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Ann Neurol 2020;87:206-16. [PMID: 31849093 DOI: 10.1002/ana.25661] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
3 McCombe PA, Wray NR, Henderson RD. Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Rev Neurother 2017;17:561-77. [PMID: 27983884 DOI: 10.1080/14737175.2017.1273772] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
4 Witzel S, Wagner M, Zhao C, Kandler K, Graf E, Berutti R, Oexle K, Brenner D, Winkelmann J, Ludolph AC. Fast Versus Slow Disease Progression in Amyotrophic Lateral Sclerosis – Clinical and Genetic Factors at the Edges of the Survival Spectrum. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.07.005] [Reference Citation Analysis]
5 Dupuis L, Petersen Å, Weydt P. Thermoregulation in amyotrophic lateral sclerosis. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Elsevier; 2018. pp. 749-60. [DOI: 10.1016/b978-0-444-64074-1.00046-x] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Jésus P, Fayemendy P, Marin B, Nicol M, Sourisseau H, Boirie Y, Walrand S, Achamrah N, Coëffier M, Preux P, Lautrette G, Couratier P, Desport J. Increased resting energy expenditure compared with predictive theoretical equations in amyotrophic lateral sclerosis. Nutrition 2020;77:110805. [DOI: 10.1016/j.nut.2020.110805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Ishikawa-Takata K, Isozaki E. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci Rep 2019;9:12262. [PMID: 31439899 DOI: 10.1038/s41598-019-48831-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang Y, Ye S, Chen L, Tang L, Fan D. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Sci Rep 2021;11:9119. [PMID: 33907295 DOI: 10.1038/s41598-021-88755-x] [Reference Citation Analysis]
9 Ferri A, Coccurello R. What is "Hyper" in the ALS Hypermetabolism? Mediators Inflamm 2017;2017:7821672. [PMID: 29081604 DOI: 10.1155/2017/7821672] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
10 Schumacher J, Peter RS, Nagel G, Rothenbacher D, Rosenbohm A, Ludolph AC, Dorst J; ALS Registry Swabia Study Group. Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population-based registry in southwest Germany. Eur J Neurol 2020;27:1405-14. [PMID: 32396653 DOI: 10.1111/ene.14300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 El Oussini H, Scekic-Zahirovic J, Vercruysse P, Marques C, Dirrig-Grosch S, Dieterlé S, Picchiarelli G, Sinniger J, Rouaux C, Dupuis L. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis. Ann Neurol 2017;82:444-56. [PMID: 28856708 DOI: 10.1002/ana.25030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ahmed RM, Caga J, Devenney E, Hsieh S, Bartley L, Highton-williamson E, Ramsey E, Zoing M, Halliday GM, Piguet O, Hodges JR, Kiernan MC. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol 2016;263:1593-603. [DOI: 10.1007/s00415-016-8168-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
13 Ahmed RM, Irish M, van Eersel J, Ittner A, Ke YD, Volkerling A, van der Hoven J, Tanaka K, Karl T, Kassiou M, Kril JJ, Piguet O, Götz J, Kiernan MC, Halliday GM, Hodges JR, Ittner LM. Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology. Neuroscience & Biobehavioral Reviews 2017;74:126-38. [DOI: 10.1016/j.neubiorev.2017.01.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ahmed RM, Steyn F, Dupuis L. Hypothalamus and weight loss in amyotrophic lateral sclerosis. Handb Clin Neurol 2021;180:327-38. [PMID: 34225938 DOI: 10.1016/B978-0-12-820107-7.00020-3] [Reference Citation Analysis]
15 Dorst J, Ludolph AC, Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord 2018;11:1756285617734734. [PMID: 29399045 DOI: 10.1177/1756285617734734] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
16 Carter GT, McLaughlin RJ, Cuttler C, Sauber GJ, Weeks DL, Hillard CJ, Weiss MD. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. Muscle Nerve 2021;63:120-6. [PMID: 33094490 DOI: 10.1002/mus.27096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ye S, Luo Y, Jin P, Wang Y, Zhang N, Zhang G, Chen L, Shi L, Fan D. MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis. Front Aging Neurosci 2021;13:610332. [PMID: 35046789 DOI: 10.3389/fnagi.2021.610332] [Reference Citation Analysis]
18 Zhang L, Chen L, Fan D. The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China. Amyotroph Lateral Scler Frontotemporal Degener 2020;21:209-15. [PMID: 31852260 DOI: 10.1080/21678421.2019.1704010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Kim WS, Halliday GM, Piguet O, Hodges JR, Farooqi IS, Kiernan MC. Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. J Alzheimers Dis 2018;61:773-83. [PMID: 29254092 DOI: 10.3233/JAD-170660] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 10.7] [Reference Citation Analysis]
20 . Theme 8 Clinical imaging and electrophysiology. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2018;19:240-63. [DOI: 10.1080/21678421.2018.1510575] [Reference Citation Analysis]
21 Wang Y, He Y, Zhu Y, He T, Xu J, Kuang Q, Ji Y, Xu R, Li F, Zhou F. Effect of the Minor C Allele of CNTN4 rs2619566 on Medial Hypothalamic Connectivity in Early-Stage Patients of Chinese Han Ancestry with Sporadic Amyotrophic Lateral Sclerosis. NDT 2022;Volume 18:437-48. [DOI: 10.2147/ndt.s339456] [Reference Citation Analysis]
22 Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, Kawata A, Isozaki E. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol 2019;266:1412-20. [PMID: 30868220 DOI: 10.1007/s00415-019-09276-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ahmed RM, Tse NY, Chen Y, Henning E, Hodges JR, Kiernan MC, Irish M, Farooqi IS, Piguet O. Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature. Ann Clin Transl Neurol 2021;8:1318-29. [PMID: 33973740 DOI: 10.1002/acn3.51369] [Reference Citation Analysis]
24 Doshi S, Gupta P, Kalb RG. Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model. Sci Rep 2017;7:13150. [PMID: 29030576 DOI: 10.1038/s41598-017-13304-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
25 Nelson AT, Trotti D. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 2022. [PMID: 35773551 DOI: 10.1007/s13311-022-01262-3] [Reference Citation Analysis]
26 Zhang CC, Zhu JX, Wan Y, Tan L, Wang HF, Yu JT, Tan L. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases. Oncotarget 2017;8:44994-5007. [PMID: 28402959 DOI: 10.18632/oncotarget.16690] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
27 Arnoux A, Ayme-Dietrich E, Dieterle S, Goy MA, Schann S, Frauli M, Monassier L, Dupuis L. Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis. Sci Rep 2021;11:23582. [PMID: 34880312 DOI: 10.1038/s41598-021-02900-0] [Reference Citation Analysis]
28 Wei QQ, Ou R, Cao B, Chen Y, Hou Y, Zhang L, Wu F, Shang H. Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis. Brain Res Bull 2021;171:10-5. [PMID: 33636227 DOI: 10.1016/j.brainresbull.2021.02.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
29 Mentis AA, Bougea AM, Chrousos GP. Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored? Aging Brain 2021;1:100024. [DOI: 10.1016/j.nbas.2021.100024] [Reference Citation Analysis]
30 Korf HW, Møller M. Arcuate nucleus, median eminence, and hypophysial pars tuberalis. Handb Clin Neurol 2021;180:227-51. [PMID: 34225932 DOI: 10.1016/B978-0-12-820107-7.00015-X] [Reference Citation Analysis]
31 Zhang L, Tang L, Huang T, Fan D. Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study. Ann Neurol 2020;87:434-41. [PMID: 31916305 DOI: 10.1002/ana.25671] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:497-505. [PMID: 31144522 DOI: 10.1080/21678421.2019.1621346] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
33 Ahmed RM, Dupuis L, Kiernan MC. Paradox of amyotrophic lateral sclerosis and energy metabolism. J Neurol Neurosurg Psychiatry 2018;89:1013-4. [PMID: 29735514 DOI: 10.1136/jnnp-2018-318428] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
34 Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, Nagel G, Ludolph AC. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol 2017;32:901-8. [PMID: 28975435 DOI: 10.1007/s10654-017-0318-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
35 Jésus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, Desport JC, Marin B, Couratier P. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol 2018;25:97-104. [PMID: 28940704 DOI: 10.1111/ene.13468] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
36 Bayer D, Antonucci S, Müller HP, Saad R, Dupuis L, Rasche V, Böckers TM, Ludolph AC, Kassubek J, Roselli F. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients. Transl Neurodegener 2021;10:17. [PMID: 34059131 DOI: 10.1186/s40035-021-00241-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Ngo ST, Mi JD, Henderson RD, McCombe PA, Steyn FJ. Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degener Neurol Neuromuscul Dis 2017;7:95-108. [PMID: 30050381 DOI: 10.2147/DNND.S120607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
38 Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC. Physiological changes in neurodegeneration - mechanistic insights and clinical utility. Nat Rev Neurol 2018;14:259-71. [PMID: 29569624 DOI: 10.1038/nrneurol.2018.23] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
39 Nagel G, Peter RS, Rosenbohm A, Koenig W, Dupuis L, Rothenbacher D, Ludolph AC. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany. Sci Rep 2017;7:4374. [PMID: 28663573 DOI: 10.1038/s41598-017-04706-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
40 Vercruysse P, Vieau D, Blum D, Petersén Å, Dupuis L. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Front Mol Neurosci 2018;11:2. [PMID: 29403354 DOI: 10.3389/fnmol.2018.00002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 14.3] [Reference Citation Analysis]
41 Martínez HR, Escamilla-Ocañas CE, Camara-Lemarroy CR, González-Garza MT, Tenorio-Pedraza JM, Hernández-Torre M. CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis. Acta Neurol Belg 2017;117:879-83. [PMID: 28550440 DOI: 10.1007/s13760-017-0798-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Cocozza G, Garofalo S, Morotti M, Chece G, Grimaldi A, Lecce M, Scavizzi F, Menghini R, Casagrande V, Federici M, Raspa M, Wulff H, Limatola C. The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca2+ -activated KCa 3.1 channels. Br J Pharmacol 2021;178:4891-906. [PMID: 34411281 DOI: 10.1111/bph.15665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Henriques A, Croixmarie V, Bouscary A, Mosbach A, Keime C, Boursier-Neyret C, Walter B, Spedding M, Loeffler JP. Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis. Front Mol Neurosci 2017;10:433. [PMID: 29354030 DOI: 10.3389/fnmol.2017.00433] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
44 Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 2018;135:489-509. [PMID: 29549424 DOI: 10.1007/s00401-018-1835-x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 94] [Article Influence: 32.5] [Reference Citation Analysis]
45 Bongioanni P, Del Carratore R, Corbianco S, Diana A, Cavallini G, Masciandaro SM, Dini M, Buizza R. Climate change and neurodegenerative diseases. Environ Res 2021;201:111511. [PMID: 34126048 DOI: 10.1016/j.envres.2021.111511] [Reference Citation Analysis]
46 Vermeiren Y, Janssens J, Van Dam D, De Deyn PP. Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. Front Neurosci 2018;12:185. [PMID: 29615862 DOI: 10.3389/fnins.2018.00185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
47 Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Takahashi K. Body Weight Gain Is Associated with the Disease Stage in Advanced Amyotrophic Lateral Sclerosis with Invasive Ventilation. Metabolites 2022;12:191. [DOI: 10.3390/metabo12020191] [Reference Citation Analysis]
48 Braun MC, Castillo-Ruiz A, Indic P, Jung DY, Kim JK, Brown RH Jr, Swoap SJ, Schwartz WJ. Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 2019;311:305-12. [PMID: 30031021 DOI: 10.1016/j.expneurol.2018.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Ferrer-Donato A, Contreras A, Frago LM, Chowen JA, Fernandez-Martos CM. Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). Int J Mol Sci 2021;22:10305. [PMID: 34638645 DOI: 10.3390/ijms221910305] [Reference Citation Analysis]